Skip to content
Fiscal Footprints
Follow the Rich
Sketch portrait of Stanley Druckenmiller
Macro · Duquesne

Stanley Druckenmiller

Duquesne Family Office
Chairman & CEO

Investing style

Global macro investing — sizing up big-picture themes (rates, currencies, growth) and expressing them through concentrated equity, ETF and derivative positions.

Famous principles
  • "It's not whether you're right or wrong, but how much you make when you're right and how much you lose when you're wrong."
  • Ride winners hard; cut losers fast.
Latest 13F Portfolio

Stanley's current holdings

As of Q4 2025 · filed 2026-02-17 · SEC filing

NoteLatest available filing — no Q1 2026 13F had been filed as of July 23, 2026. Q4 saw a notable pivot into broad ETFs (new XLF and equal-weight S&P positions) alongside big biotech trims.
Total portfolio value
$4.49B
Positions
62
Largest holding
NTRA · 12.8%
Biggest move this quarter
New: XLF $301.0M
Allocation

Top 8 holdings + Other

TickerCompanyValue% of PortfolioChange
Natera Inc$575.3M12.80%trimmed
Financial Select Sector SPDR$301.0M6.70%new
Insmed Inc$257.9M5.74%trimmed
Invesco S&P 500 Equal Weight ETF$224.9M5.00%new
Teva Pharmaceutical (ADS)$183.4M4.08%trimmed
Woodward Inc$178.7M3.97%trimmed
Amazon.com Inc$170.3M3.79%added
Taiwan Semiconductor (ADS)$165.0M3.67%trimmed
Coupang Inc (Cl A)$159.8M3.55%added
EWZCALLS
iShares MSCI Brazil ETF$134.3M2.99%new

Showing top 10 of 62 reported positions.

What changed this quarter
  • trimmedNTRANatera Inc
  • newXLFFinancial Select Sector SPDR
  • trimmedINSMInsmed Inc
  • newRSPInvesco S&P 500 Equal Weight ETF
  • trimmedTEVATeva Pharmaceutical (ADS)
  • trimmedWWDWoodward Inc
  • addedAMZNAmazon.com Inc
  • trimmedTSMTaiwan Semiconductor (ADS)
  • addedCPNGCoupang Inc (Cl A)
  • newEWZiShares MSCI Brazil ETF
  • exitedVRNAVerona Pharma
  • exitedMETAMeta Platforms
  • exitedCRSCarpenter Technology
  • exitedCCitigroup
  • exitedTWLOTwilio
  • exitedBACBank of America
  • exitedEQTEQT Corp
  • exitedGEVGE Vernova
  • exitedVSTVistra